December 24, 2024
The why and what next Dexcom Abbott
Frankly I am somewhat in a state of shock not because Abbott and Dexcom settled their long running IP battle, but that common sense prevailed over stupidity. That Abbott CEO Robert Ford did the right thing and did not let his oversized ego get in the way. We can now get back to fighting over market share and building a presence in the OTC market. In other words, we can get back to the business of CGM and out of the court room.
Given it’s the holiday season the folks at Dexcom should also send a bottle of champagne . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
